CALR and myeloproliferative disorder: Identification of an acquired, clonal mutation has become a fundamental aspect of ET diagnosis [2] with identification of mutations of JAK2, MPL, and CALR likely to be incorporated into the revised World Health Organization diagnostic criteria for this MPN [3].